Clinical Trial Update: Early Versus Late Adjunctive Vasopressin in Septic Shock [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating early versus late adjunctive vasopressin therapy in septic shock, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Sepsis, Septic Shock | Phase 4 | Status: RECRUITING